University of Kentucky Medical Center Center for Clinical and Translational Science
Welcome,         Profile    Billing    Logout  
 5 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kern, Philip A
NCT05051436: The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

Recruiting
4
96
US
Mirabegron 50 MG, Tadalafil 10 MG, Placebo
Philip Kern, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Pre-diabetes, Obesity
12/24
02/25
NCT06721507: 2024 Tirzepatide-Bariatric Surgery

Recruiting
4
50
US
tirzepatide, Mounjaro, Zepbound, Standard of Care
Marlene Starr
Obesity and Obesity-related Medical Conditions, Bariatric Surgery
12/26
12/26
NCT04666636: Mechanisms for Activation of Beige Adipose Tissue in Humans

Recruiting
2
65
US
Placebo, Mirabegron, Myrbetriq
Philip Kern, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
PreDiabetes
12/24
12/24
TIMER, NCT04500769: Training Induced Muscle Exosome Release

Active, not recruiting
N/A
38
US
Acute Resistance Exercise, Strength Training
Yuan Wen, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Metabolism
11/25
11/26
M-Recover, NCT05537298: Muscle Recovery After Critical Illness

Recruiting
N/A
206
US
Kirby Mayer, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Oklahoma Medical Research Foundation, University of Alabama at Birmingham
ICU Acquired Weakness, Post Intensive Care Unit Syndrome, Muscle Weakness, Critical Illness
07/27
08/27
Harfmann, Brianna
No trials found

Download Options